Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005;7 Suppl 4(Suppl 4):S3-S12.

Pathophysiology of benign prostatic hyperplasia in the aging male population

Pathophysiology of benign prostatic hyperplasia in the aging male population

Herbert Lepor. Rev Urol. 2005.

Abstract

Nearly all men will develop histological benign prostatic hyperplasia by the age of 80, but the degree of prostatic enlargement resulting from the hyperplasia is highly variable. Historically, it has often been assumed that the pathophysiology of lower urinary tract symptoms (LUTS) in men is the result of bladder outlet obstruction associated with prostatic enlargement. The observation that prostatic enlargement, bladder outlet obstruction, and LUTS are all age-dependent has been interpreted to indicate that these phenomena were causally related, but there is insufficient evidence for this. Undoubtedly, some men' prostatic enlargement causes obstruction and symptoms. Based upon the available data, however, this subset appears to be extremely small. Because of the many urological and nonurological conditions that cause LUTS and age-dependent changes in bladder and neurological function, it is unlikely that there exists a single dominant etiology for the aging male population. If this is the case, then the optimal management of LUTS will require different and possibly combination therapies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimated median prostate volume as a function of age for the finasteride North American Study, VA Study, and Olmsted County Community Study. Reproduced from Boyle et al,13 with permission from the publisher, Elsever Science.

Similar articles

Cited by

References

    1. McNeal JG. The prostate gland: morphology and pathobiology. Monogr Urol. 1983;4:3–33.
    1. Berry SJ, Coffey DS, Walsh PC, et al. The development of human prostatic hyperplasia with age. J Urol. 1984;132:474–479. - PubMed
    1. Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of health men: establishment of age-specific reference ranges. JAMA. 1993;270:860–864. - PubMed
    1. Barry MJ, O'Leary MP. The development and clinical utility of symptom scores. Urol Clin N Am. 1995;22:229–307. - PubMed
    1. Jacobsen SJ, Girman CJ, Lieber MM. Natural history of benign prostatic hyperplasia. Urology. 2001;58(suppl 1):5–16. - PubMed

LinkOut - more resources